MF: C19H28N2O4 MW: 348.44 A β-AR, SR-1A, and SR-1B antagonist.
Protein-Interacting Inhibitors, Activators & Substrates
SDZ 21009 (CAS 39731-05-0)
4-[3-[(1,1-Dimethylethyl)amino]-2-hydroxypropoxy]-1H-indole-2-carboxylic acid, 1-methylethyl ester
SDZ 21009 is a β-AR, SR-1A, and SR-1B antagonist
C 19H 28N 2O 4
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use. Available in US only. *
Certificate of Analysis for lot specific data (including water content).
Click on image or enlarge button to enlarge
SDZ 21009 is a β-AR adrenoceptor antagonist. It has also demonstrated ability to be an SR-1A and SR-1B antagonist as well.
1. Engel, G., et al. 1986. Naunyn-Schmied. Arch. Pharmacol. 332: 1-7.
2. Chojnacka-Wojcik, E. and Przegalinski, E. 1991. Neuropharmacology. 30: 703-709. 3. Hoyer, D., et al. 1994. Pharmacol. Rev. 46: 157-203.
Soluble to 100 mM in Ethanol and to 100 mM in DMSO
Store at room temperature
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use. Available in US only.
Adobe Acrobat Reader is required to reliably view,
print and comment on PDF documents
Santa Cruz Biotechnology, Inc. is a world leader in the development of products for the biomedical research market. Call us Toll Free at
Copyright © 2007-2021 Santa Cruz Biotechnology, Inc. All Rights Reserved. "Santa Cruz Biotechnology", and the Santa Cruz Biotechnology, Inc. logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", the San Juan Ranch logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", and "EZ Touch" are registered trademarks of Santa Cruz Biotechnology, Inc.
All trademarks are the property of their respective owners.